cdmo.directory
← Compare landing

Biomay AG vs Quintara Biosciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/biomay/quintarabio

CategoryBiomay AGQuintara Biosciences
Listed sitecdmoboth
SummaryGMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.Quintara Biosciences offers Sanger, nanopore, NGS, and PacBio sequencing, plus gene synthesis, AAV plasmid preparation, and IVT mRNA with LNP encapsulation. Its services are aimed at research and preclinical programs that need sequence-verified constructs and mRNA workflows.
Services
  • mRNA Manufacturing
  • Cell-Line Development
  • Recombinant Protein Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Genomics & Sequencing Services
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Protein Engineering
Modalities
  • mRNA
  • Gene Therapy
  • mRNA
  • Gene Therapy
  • Biologics (Monoclonal Antibodies)
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Vienna, Austria
Data not yet provided.
Certifications
  • EMA · Identifier: GMP
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.